4//SEC Filing
IDERA PHARMACEUTICALS, INC. 4
Accession 0001209191-13-056621
CIK 0000861838operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:49 PM ET
Size
5.3 KB
Accession
0001209191-13-056621
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option
2013-12-10+200,000→ 200,000 totalExercise: $2.56Exp: 2023-12-10→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests in equal quarterly installments over four years, with the first installment vesting on March 10, 2014.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000861838
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:49 PM ET
- Size
- 5.3 KB